The role and mechanisms of methylation modifications in the development and progression of hypertension
Authors:
Open Access
- 18 April 2026
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 118, 103146
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2024YFC3506302)
This publication has 121 references indexed in Scilit:
- METTL3-mediated m⁶A methylation in cardiac diseases: pathogenic roles and therapeutic potentialCell Biology and Toxicology, 2025
- Treatment of HypertensionJAMA, 2022
- DNA Methylation Signatures as Biomarkers of Prior Environmental ExposuresCurrent Epidemiology Reports, 2019
- Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertensionMolecular Biology Reports, 2014
- Lysine-specific demethylase-1 modifies the age effect on blood pressure sensitivity to dietary salt intakeAGE, 2012
- A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism.Clinical and Experimental Medicine, 2002
- A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme ActivityMolecular Genetics and Metabolism, 1998
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityCell, 1992
- A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNACell, 1985